Fulcrum Therapeutics Inc (FULC)
7.85
+0.20
(+2.61%)
USD |
NASDAQ |
May 31, 16:00
7.85
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Accounts Payable (Quarterly): 3.857M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.857M |
December 31, 2023 | 2.757M |
September 30, 2023 | 3.574M |
June 30, 2023 | 3.909M |
March 31, 2023 | 3.778M |
December 31, 2022 | 3.638M |
September 30, 2022 | 2.728M |
June 30, 2022 | 5.385M |
March 31, 2022 | 6.003M |
December 31, 2021 | 4.788M |
September 30, 2021 | 3.742M |
Date | Value |
---|---|
June 30, 2021 | 4.498M |
March 31, 2021 | 4.797M |
December 31, 2020 | 4.079M |
September 30, 2020 | 3.634M |
June 30, 2020 | 3.571M |
March 31, 2020 | 3.937M |
December 31, 2019 | 2.186M |
September 30, 2019 | 4.533M |
June 30, 2019 | 3.081M |
March 31, 2019 | 2.522M |
December 31, 2018 | 1.263M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.186M
Minimum
Dec 2019
6.003M
Maximum
Mar 2022
3.924M
Average
3.818M
Median
Accounts Payable (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 3.539B |
Moderna Inc | 183.00M |
Pfizer Inc | 5.591B |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |